stockrow
Friday 6 November 2026
Export AXGN’s income statement to Excel — free account
AxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +178.3%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
50.00
1.25
+2.56%
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Net income
AxoGen, Inc.'s net income for fiscal 2025 was −$15.7M, compared with −$10.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$31.9M. Over the past ten years it has ranged from −$29.1M (fiscal 2019) to −$10.0M (fiscal 2024); the current reading is higher than 64% of that period. AxoGen, Inc. ranks 93rd of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$15.7M | — |
| FY2024 | −$10.0M | — |
| FY2023 | −$21.7M | — |
| FY2022 | −$28.9M | — |
| FY2021 | −$27.0M | — |
| FY2020 | −$23.8M | — |
| FY2019 | −$29.1M | — |
| FY2018 | −$22.4M | — |
| FY2017 | −$10.4M | — |
| FY2016 | −$14.4M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $2.3M | — |
| Jun 2026 | −$1.5M | — |
| Mar 2026 | −$19.6M | — |
| Dec 2025 | −$13.2M | — |
| 43 more quarters | Free account |
Against its own ten years
Low −$29.1M
High −$10.0M
Ten-year median
−$21.7M
Current reading's percentile
64
Net income against peers
| Company | Net income |
|---|---|
| TMDX TransMedics Group, Inc. compare | $144.5M |
| ITGR Integer Holdings Corporation compare | $103.7M |
| INSP Inspire Medical Systems, Inc. compare | $100.7M |
| UFPT UFP Technologies, Inc. compare | $72.3M |
| AXGN AxoGen, Inc. | −$31.9M |
| IRTC iRhythm Holdings, Inc. compare | −$38.6M |
| ESTA Establishment Labs Holdings Inc. compare | −$38.9M |
| NEOG Neogen Corporation compare | −$56.1M |
| ALMR Alamar Biosciences, Inc. compare | −$77.7M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on AXGN
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement